The prescription is the start of GLP-1 care, not the product. What separates a medical program from a subscription box is everything that happens after: dose checks, side-effect triage, lab review, titration decisions. Here's the follow-up cadence competent programs run — and how to audit yours.
Key Takeaways
- Titration phase standard: a touchpoint at each dose change, roughly every 4 weeks, before the increase ships.
- Maintenance phase standard: scheduled check-ins every 3 months, plus labs at 6–12 month intervals if indicated.
- The red flag isn't infrequent visits — it's dose increases that ship with no clinical contact at all.
- Message response time under 1 business day for side-effect questions is the service bar; test it early.
Why Cadence Is a Safety Feature
Titration is a series of clinical decisions: is the current dose tolerated, is it working, should it increase? Each escalation raises side-effect probability, so each should be gated on how you're actually doing. A program that auto-ships 0.25 → 0.5 → 1.0 → 1.7 → 2.4mg on a calendar, with no human asking how you're tolerating it, has removed the medicine and kept the logistics.
The Titration-Phase Standard
Before each dose increase (typically every 4 weeks): a check-in — async questionnaire, portal message exchange, or brief video — covering side effects, adherence, and weight trend, with a clinician sign-off on the escalation. Async check-ins are perfectly legitimate here; the test is whether your answers can actually change the plan. Report significant nausea and watch what happens: a real program offers to hold the dose; a pipeline ships the increase anyway.
The Maintenance-Phase Standard
Once stable at an effective dose, the cadence relaxes: a scheduled review every 3 months (weight trend, side effects, goals) and periodic labs — A1C and lipids at 6–12 months if they were abnormal at baseline. Many states' prescribing rules also require periodic re-evaluation to keep refilling; a provider who never re-evaluates may be cutting a legal corner, not just a clinical one.
Auditing Your Provider This Week
- Count contacts. How many times has a clinician (not billing) initiated contact since you started? Titration months should each have one.
- Test the channel. Send a genuine clinical question. Under one business day for a substantive reply is the bar.
- Check the gate. Did your last dose increase follow a check-in, or just a calendar?
- Ask about labs. If baseline labs were abnormal and nobody has mentioned a recheck, mention it yourself — the response tells you everything.
Programs With Real Follow-Up Structure
Enhance MD
Injectable GLP-1 program
Established telehealth clinic with injectable GLP-1 protocols and live provider access.
Compounded medications are not FDA-approved.
Visit Enhance MD Paid linkEmbody
Injectable semaglutide — $149 first month
Physician-supervised injectable semaglutide with fast async intake and flat pricing after month one.
Compounded medications are not FDA-approved.
Visit Embody Paid linkFound Health
Dissolvable tablets — sema $189/4wk
Compounded dissolvable semaglutide with structured coaching built in.
Compounded medications are not FDA-approved.
Visit Found Health Paid linkYou're paying monthly for medical supervision. Cadence is what supervision looks like from the outside — audit it like the service it's supposed to be.
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.